Development and Validation of a Deep Learning Method to Predict Cerebral Palsy From Spontaneous Movements in Infants at High Risk.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 07 2022
Historique:
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

Early identification of cerebral palsy (CP) is important for early intervention, yet expert-based assessments do not permit widespread use, and conventional machine learning alternatives lack validity. To develop and assess the external validity of a novel deep learning-based method to predict CP based on videos of infants' spontaneous movements at 9 to 18 weeks' corrected age. This prognostic study of a deep learning-based method to predict CP at a corrected age of 12 to 89 months involved 557 infants with a high risk of perinatal brain injury who were enrolled in previous studies conducted at 13 hospitals in Belgium, India, Norway, and the US between September 10, 2001, and October 25, 2018. Analysis was performed between February 11, 2020, and September 23, 2021. Included infants had available video recorded during the fidgety movement period from 9 to 18 weeks' corrected age, available classifications of fidgety movements ascertained by the general movement assessment (GMA) tool, and available data on CP status at 12 months' corrected age or older. A total of 418 infants (75.0%) were randomly assigned to the model development (training and internal validation) sample, and 139 (25.0%) were randomly assigned to the external validation sample (1 test set). Video recording of spontaneous movements. The primary outcome was prediction of CP. Deep learning-based prediction of CP was performed automatically from a single video. Secondary outcomes included prediction of associated functional level and CP subtype. Sensitivity, specificity, positive and negative predictive values, and accuracy were assessed. Among 557 infants (310 [55.7%] male), the median (IQR) corrected age was 12 (11-13) weeks at assessment, and 84 infants (15.1%) were diagnosed with CP at a mean (SD) age of 3.4 (1.7) years. Data on race and ethnicity were not reported because previous studies (from which the infant samples were derived) used different study protocols with inconsistent collection of these data. On external validation, the deep learning-based CP prediction method had sensitivity of 71.4% (95% CI, 47.8%-88.7%), specificity of 94.1% (95% CI, 88.2%-97.6%), positive predictive value of 68.2% (95% CI, 45.1%-86.1%), and negative predictive value of 94.9% (95% CI, 89.2%-98.1%). In comparison, the GMA tool had sensitivity of 70.0% (95% CI, 45.7%-88.1%), specificity of 88.7% (95% CI, 81.5%-93.8%), positive predictive value of 51.9% (95% CI, 32.0%-71.3%), and negative predictive value of 94.4% (95% CI, 88.3%-97.9%). The deep learning method achieved higher accuracy than the conventional machine learning method (90.6% [95% CI, 84.5%-94.9%] vs 72.7% [95% CI, 64.5%-79.9%]; P < .001), but no significant improvement in accuracy was observed compared with the GMA tool (85.9%; 95% CI, 78.9%-91.3%; P = .11). The deep learning prediction model had higher sensitivity among infants with nonambulatory CP (100%; 95% CI, 63.1%-100%) vs ambulatory CP (58.3%; 95% CI, 27.7%-84.8%; P = .02) and spastic bilateral CP (92.3%; 95% CI, 64.0%-99.8%) vs spastic unilateral CP (42.9%; 95% CI, 9.9%-81.6%; P < .001). In this prognostic study, a deep learning-based method for predicting CP at 9 to 18 weeks' corrected age had predictive accuracy on external validation, which suggests possible avenues for using deep learning-based software to provide objective early detection of CP in clinical settings.

Identifiants

pubmed: 35816301
pii: 2794119
doi: 10.1001/jamanetworkopen.2022.21325
pmc: PMC9274325
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2221325

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR001424
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Brain. 2011 Aug;134(Pt 8):2197-221
pubmed: 21784775
Pediatrics. 2012 Nov;130(5):e1285-312
pubmed: 23045562
Res Dev Disabil. 2021 Mar;110:103854
pubmed: 33571849
Arch Dis Child Fetal Neonatal Ed. 2022 Jan;107(1):32-38
pubmed: 34112719
Sensors (Basel). 2020 Sep 17;20(18):
pubmed: 32957598
Ment Retard Dev Disabil Res Rev. 2005;11(1):61-7
pubmed: 15856440
J Clin Med. 2019 Oct 25;8(11):
pubmed: 31717717
J Pediatr (Rio J). 2016 May-Jun;92(3 Suppl 1):S64-70
pubmed: 26997356
Dev Med Child Neurol. 2018 Jan;60(1):39-46
pubmed: 28832987
JAMA Pediatr. 2021 Aug 1;175(8):846-858
pubmed: 33999106
Front Neurol. 2015 Jan 09;5:284
pubmed: 25620954
Early Hum Dev. 2015 Apr;91(4):247-52
pubmed: 25748086
Sci Rep. 2021 May 10;11(1):9888
pubmed: 33972661
Physiother Theory Pract. 2013 Aug;29(6):469-75
pubmed: 23343036
BMJ Open. 2021 Mar 4;11(3):e042147
pubmed: 33664072
Comput Med Imaging Graph. 2022 Jan;95:102012
pubmed: 34864580
IEEE J Biomed Health Inform. 2021 Oct;25(10):3911-3920
pubmed: 33956636
Arch Dis Child. 2000 Dec;83(6):475-80
pubmed: 11087279
IEEE Trans Pattern Anal Mach Intell. 2022 Mar 07;PP:
pubmed: 35254974
Lancet. 1997 May 10;349(9062):1361-3
pubmed: 9149699
J Pediatr. 2008 Jul;153(1):32-9
pubmed: 18571531
J Paediatr Child Health. 2022 May;58(5):796-801
pubmed: 34850486
Dev Med Child Neurol. 2000 Dec;42(12):816-24
pubmed: 11132255
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
Dev Med Child Neurol. 2018 May;60(5):480-489
pubmed: 29468662
Sci Rep. 2022 Feb 24;12(1):3138
pubmed: 35210507
J Pediatr. 2018 Dec;203:156-162
pubmed: 30244983
BMJ Open. 2016 Oct 3;6(10):e013446
pubmed: 27697883
Eur J Paediatr Neurol. 2021 Jul;33:29-35
pubmed: 34052727
IEEE Trans Neural Syst Rehabil Eng. 2012 Jul;20(4):605-14
pubmed: 22531824
Dev Med Child Neurol. 2010 Aug;52(8):773-8
pubmed: 20187882
J Clin Med. 2019 Oct 04;8(10):
pubmed: 31590221
Early Hum Dev. 2021 Oct;161:105436
pubmed: 34375936
Front Neurol. 2020 Jul 16;11:704
pubmed: 32765409
Dev Med Child Neurol. 2009 Jan;51(1):46-52
pubmed: 19018834
J Clin Med. 2019 Dec 18;9(1):
pubmed: 31861380
IEEE Trans Neural Syst Rehabil Eng. 2016 Nov;24(11):1225-1234
pubmed: 27046852
Dev Med Child Neurol. 2017 Jun;59(6):618-624
pubmed: 28102574
Pediatrics. 2018 Jan;141(1):
pubmed: 29222398
Curr Neurol Neurosci Rep. 2017 May;17(5):43
pubmed: 28390033
J Perinatol. 2007 Apr;27(4):225-9
pubmed: 17304207
JAMA Pediatr. 2017 Sep 1;171(9):897-907
pubmed: 28715518
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258
Eur J Paediatr Neurol. 2020 Nov;29:54-61
pubmed: 32988734
Pediatrics. 2015 May;135(5):e1220-8
pubmed: 25896840
Early Hum Dev. 1990 Sep;23(3):151-8
pubmed: 2253578
Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:3598-3601
pubmed: 30441155
Dev Med Child Neurol. 2013 May;55(5):418-26
pubmed: 23574478
Physiol Meas. 2019 Feb 26;40(2):02TR02
pubmed: 30669130
Res Dev Disabil. 2021 Nov;118:104071
pubmed: 34507051

Auteurs

Daniel Groos (D)

Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.

Lars Adde (L)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Clinic of Clinical Services, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Sindre Aubert (S)

Department of Computer Science, Norwegian University of Science and Technology, Trondheim, Norway.

Lynn Boswell (L)

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

Raye-Ann de Regnier (RA)

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Toril Fjørtoft (T)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Clinic of Clinical Services, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Deborah Gaebler-Spira (D)

Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Shirley Ryan AbilityLab, Chicago, Illinois.

Andreas Haukeland (A)

Department of Computer Science, Norwegian University of Science and Technology, Trondheim, Norway.

Marianne Loennecken (M)

Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Michael Msall (M)

Section of Developmental and Behavioral Pediatrics, University of Chicago, Comer Children's Hospital, Chicago, Illinois.
Kennedy Research Center on Neurodevelopmental Disabilities, University of Chicago, Comer Children's Hospital, Chicago, Illinois.

Unn Inger Möinichen (UI)

Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Aurelie Pascal (A)

Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, Belgium.

Colleen Peyton (C)

Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Department of Pediatrics, University of Chicago, Comer Children's Hospital, Chicago, Illinois.

Heri Ramampiaro (H)

Department of Computer Science, Norwegian University of Science and Technology, Trondheim, Norway.

Michael D Schreiber (MD)

Department of Pediatrics, University of Chicago, Comer Children's Hospital, Chicago, Illinois.

Inger Elisabeth Silberg (IE)

Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Nils Thomas Songstad (NT)

Department of Pediatrics and Adolescent Medicine, University Hospital of North Norway, Tromsø, Norway.

Niranjan Thomas (N)

Department of Neonatology, Christian Medical College Vellore, Vellore, Tamil Nadu, India.

Christine Van den Broeck (C)

Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, Belgium.

Gunn Kristin Øberg (GK)

Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Department of Health and Care Sciences, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway.

Espen A F Ihlen (EAF)

Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.

Ragnhild Støen (R)

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Neonatology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH